Actavia Life Sciences Inc 's

• RASP's Stock Performance relative to its Competitors

Tiziana Life Sciences Ltd Share Performance -38.32% One Year

Tiziana Life Sciences Ltd Profile Tiziana Life Sciences Ltd's business model focuses on the development and commercialization of innovative therapeutics in the field of immunology and oncology. More about Tiziana Life Sciences Ltd's Market Share

Azitra Inc Share Performance -3.23% Over The Past 5 Days

Azitra Inc Profile Azitra Inc is a company that operates on a business model focused on developing and commercializing microbiome-based therapeutics for various skin conditions. It aims to use the potential of the human skin microbiome to develop innovative and effective treatments. More about Azitra Inc 's Market Share

Novartis Ag Share Performance +27.00% One Year

Novartis Ag Profile Novartis AG's business model is centered around the development, manufacturing, and marketing of innovative pharmaceutical products. More about Novartis Ag's Market Share

Sanofi Share Performance -1.14% Over The Past 5 Days

Sanofi Profile Sanofi's business model revolves around the development, production, and distribution of pharmaceutical products. They aim to innovate and provide healthcare solutions across various therapeutic areas to improve patients' lives worldwide. Sanofi collaborates with partners and healthcare professionals to ensure effective delivery of their products and to address evolving patient needs. More about Sanofi's Market Share

Sources: Actavia Life Sciences Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on: Friday, September 4, 2026 10:02 AM
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Actavia Life Sciences Inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.